Eric Bjerkholt

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Kengsington, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Eric Bjerkholt by Chrystal N. Jensen - attoney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Eric Bjerkholt

Form 4 holding Director

CERUS CORP

Security class
Common Stock
Shares / value
261,679
Estimated value
$680,365
Report date
09 Jun 2026
Price
$2.60
Ownership
Direct
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
11,760
Estimated value
$255,581
Report date
28 Jan 2026
Price
$47.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
26,653
Estimated value
Report date
09 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CalciMedica, Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
10,000
Estimated value
Report date
27 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Performance Restricted Stock Units
Shares / value
6,666
Estimated value
Report date
15 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Director Stock Option (right to buy)
Shares / value
5,550
Estimated value
Report date
13 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
14 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surrozen, Inc./DE

Security class
Option (right to buy)
Shares / value
1,333
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

CHINOOK THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

CHINOOK THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$26.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Eric Bjerkholt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .